Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Clinical advances in cancer molecular testing: the patient's perspective

Best of ASCO® 2025 Miami Symposium

Published: 31 Jul 2025

Views: 194

Rating:

Save

Paul Hakimata - Memorial Healthcare System, Miami, USA

Patients go through a screening process for nodules that may signal cancer, with diagnosis taking one to three weeks.

Oncologists need genetic testing to find targetable mutations for better therapies. Without this information, patients often face traditional chemotherapy, limiting future options. New methods aim to speed up genetic result turnaround, improving treatment outcomes.

The field is evolving with more data and potential AI integration for enhanced strategies.

Related Videos

ASCO 2025: Developments in the treatment of soft tissue sarcoma

Dr Atif Hussein - Memorial Cancer Institute, Miami, USA

ASCO 2025: Developments in the treatment of soft tissue sarcoma ( Dr Atif Hussein - Memorial Cancer Institute, Miami, USA )

Updates on gastrointestinal cancer treatments ASCO 2025

Dr Mike Cusnir - Mount Sinai Medical Center, Miami, USA

Updates on gastrointestinal cancer treatments ASCO 2025 ( Dr Mike Cusnir - Mount Sinai Medical Center, Miami, USA )

Advancements in gastrointestinal cancer treatments at ASCO 2025

Dr Jesus Fabregas - Memorial Cancer Institute, Miami, USA

Advancements in gastrointestinal cancer treatments at ASCO 2025 ( Dr Jesus Fabregas - Memorial Cancer Institute, Miami, USA )

Future of chemotherapy and targeted therapies

Dr Natasha Rueth - Memorial Cancer Institute, Miami, USA

Future of chemotherapy and targeted therapies ( Dr Natasha Rueth - Memorial Cancer Institute, Miami, USA )

Breast cancer survivorship

Dr Luzia Travado, Dr Christina Signorelli and Dr Beverley Lim Høeg

Breast cancer survivorship ( Dr Luzia Travado, Dr Christina Signorelli and Dr Beverley Lim Høeg )

Burden and trends of breast cancer worldwide: Opportunities for prevention?

Dr Eileen Morgan, Dr Isabelle Soerjomataram and Dr Shalaka Joshi

Burden and trends of breast cancer worldwide: Opportunities for prevention? ( Dr Eileen Morgan, Dr Isabelle Soerjomataram and Dr Shalaka Joshi )

ELCC 2025: Latest in EGFR positive NSCLC

Dr Antonio Passaro, Prof Nicolas Girard, Prof Raffaele Califano and Dr Anna Minchom

ELCC 2025: Latest in EGFR positive NSCLC ( Dr Antonio Passaro, Prof Nicolas Girard, Prof Raffaele Califano and Dr Anna Minchom )

Digital pathology superior to manual SP263 PD-L1 TC scoring for stage II-IIIA high PD-L1 expression NSCLC

Prof Martin Reck - German Center of Lung Research, Grosshansdorf, Germany

Digital pathology superior to manual SP263 PD-L1 TC scoring for stage II-IIIA high PD-L1 expression NSCLC ( Prof Martin Reck - German Center of Lung Research, Grosshansdorf, Germany )

Enhancing medicine safety monitoring in Zambia

Mulubwa Chilambe - Zambia Medicines Regulatory Authority (ZAMRA), Lusaka, Zambia

Enhancing medicine safety monitoring in Zambia ( Mulubwa Chilambe - Zambia Medicines Regulatory Authority (ZAMRA), Lusaka, Zambia )

More from ecancer